Table 1.
Anthropometric and Biochemical Characteristics of Study Population at Baseline and Study End
| Clinical parameters | SAL BAS | EXE BAS | SAL EOS | EXE EOS |
P value |
|||
|---|---|---|---|---|---|---|---|---|
| SAL BAS vs EXE BAS | SAL BAS vs SAL EOS | EXE BAS vs EXE EOS | SAL EOS vs EXE EOS | |||||
| Age (years) | 10.9 ± 4.7 | 10.8 ± 6.9 | 0.45 | |||||
| Sex (M:F ratio) | 7:19 | 7:19 | 0.89 | |||||
| BMI (kg/m2) | 22.5 ± 8.3 | 23.3 ± 7.6 | 21.4 ± 8.8 | 22.1 ± 6.5 | 0.89 | 0.003 | 0.001 | 0.90 |
| Waist (m) | 0.48 ± 0.1 | 0.5 ± 0.2 | 0.47 ± 0.1 | 0.47 ± 0.1 | 0.35 | 0.76 | 0.003 | 0.87 |
| FPG (mmol/L) | 4.46 ± 0.12 | 4.56 ± 0.21 | 4.45 ± 0.13 | 4.53 ± 0.22 | 0.69 | 0.57 | 0.17 | 0.91 |
| HbA1c [% (mmol/mol)] | 4.1 ± 0.4 (21.3 ± 4.4) | 4.3 ± 0.3 (23.5 ± 3.3) | 4.3 ± 0.8 (23.5 ± 8.7) | 4.3 ± 0.6 (23.5 ± 6.6) | 0.08 | 0.06 | 0.30 | 0.98 |
| Albumin (g/L) | 39.1 ± 1.0 | 39.1 ± 1.1 | 36.0 ± 1.0 | 36.1 ± 1.1 | 0.75 | 0.07 | 0.08 | 0.87 |
| ALT (μkat/L) | 0.57 ± 0.20 | 0.49 ± 0.23 | 0.53 ± 0.32 | 0.46 ± 0.23 | 0.68 | 0.87 | 0.065 | 0.12 |
| Amylase (μkat/L) | 2.27 ± 0.48 | 2.52 ± 1.14 | 2.24 ± 0.92 | 2.34 ± 0.99 | 0.32 | 0.80 | 0.90 | 0.78 |
| Creatinine (μmol/L) | 90.2 ± 3.5 | 92.8 ± 3.5 | 85.8 ± 3.5 | 84.9 ± 3.5 | 0.65 | 0.044 | 0.047 | 0.81 |
| Tot. Chol (mmol/L) | 2.43 ± 0.11 | 2.62 ± 0.12 | 2.67 ± 0.12 | 2.80 ± 0.13 | 0.35 | 0.13 | 0.15 | 0.47 |
| HDL (mmol/L) | 1.06 ± 0.04 | 1.14 ± 0.05 | 1.09 ± 0.06 | 1.17 ± 0.08 | 0.2 | 0.60 | 0.80 | 0.45 |
| LDL (mmol/L) | 1.14 ± 0.06 | 1.19 ± 0.07 | 1.24 ± 0.08 | 1.27 ± 0.08 | 0.55 | 0.02 | 0.24 | 0.76 |
| Trigly (mmol/L) | 0.52 ± 0.24 | 0.51 ± 0.29 | 0.61 ± 0.34 | 0.69 ± 0.34 | 0.96 | 0.037 | 0.043 | 0.75 |
ALT, alanine transaminase; BAS, baseline; BMI, body mass index; EOS, end of study; EXE, exenatide; F, female; M, male; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SAL, saline; Tot. Chol, total cholesterol; Trigly, triglycerides.